UBS initiated coverage on American Healthcare REIT with a new price target
$AHR
Real Estate Investment Trusts
Real Estate
UBS initiated coverage of American Healthcare REIT with a rating of Buy and set a new price target of $51.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/29/2026 | $55.00 | Outperform | BMO Capital Markets |
| 9/19/2025 | $51.00 | Buy | UBS |
| 7/18/2025 | $41.00 | Outperform | Robert W. Baird |
| 6/30/2025 | $42.00 | Sector Outperform | Scotiabank |
| 4/28/2025 | $37.00 | Buy | Jefferies |
| 3/14/2024 | $18.00 | Overweight | Barclays |
| 3/4/2024 | $15.00 | Buy | BofA Securities |
| 3/4/2024 | $16.00 | Mkt Outperform | JMP Securities |
BMO Capital Markets initiated coverage of American Healthcare REIT with a rating of Outperform and set a new price target of $55.00
UBS initiated coverage of American Healthcare REIT with a rating of Buy and set a new price target of $51.00
Robert W. Baird initiated coverage of American Healthcare REIT with a rating of Outperform and set a new price target of $41.00
IRVINE, Calif., Feb. 26, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," "management," "us," or "AHR") is announcing today its fourth quarter and full year 2025 results and issuing full year 2026 guidance. Key Highlights:Reported GAAP net income attributable to controlling interest of $10.8 million, or $0.06 per diluted share, for the three months ended December 31, 2025; and GAAP net income attributable to controlling interest of $69.8 million, or $0.42 per diluted share, for the year ended December 31, 2025.Reported Normalized Funds
IRVINE, Calif., Feb. 25, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR), announced today that Chief Financial Officer, Brian S. Peay, Chief Operating Officer, Gabe M. Willhite, and VP of Investor Relations & Finance, Alan Peterson, will participate in a roundtable discussion at the Citi 2026 Global Property CEO Conference on Wednesday, March 4, 2026, from 8:10 to 8:45 a.m. Eastern Time. A live webcast of the presentation will be available at the following link. A replay will be available for one year utilizing the same link following the completion of the conference on March 4, 2026.
IRVINE, Calif., Feb. 4, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," or "AHR") announced today that Danny Prosky, the Company's Chief Executive Officer and President, has taken a medical leave of absence, effective February 3, 2026, due to a recent medical event. The Company's Board of Directors has appointed Jeffrey T. Hanson, the Chairman of the Company's Board, to serve as Interim Chief Executive Officer and President, effective February 3, 2026, during Mr. Prosky's absence. Mr. Hanson will work closely with AHR's senior leade
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
SCHEDULE 13G - American Healthcare REIT, Inc. (0001632970) (Subject)
SCHEDULE 13G/A - American Healthcare REIT, Inc. (0001632970) (Subject)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc
IRVINE, Calif., Feb. 26, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," "management," "us," or "AHR") is announcing today its fourth quarter and full year 2025 results and issuing full year 2026 guidance. Key Highlights:Reported GAAP net income attributable to controlling interest of $10.8 million, or $0.06 per diluted share, for the three months ended December 31, 2025; and GAAP net income attributable to controlling interest of $69.8 million, or $0.42 per diluted share, for the year ended December 31, 2025.Reported Normalized Funds
IRVINE, Calif., Feb. 4, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," or "AHR") announced today that Danny Prosky, the Company's Chief Executive Officer and President, has taken a medical leave of absence, effective February 3, 2026, due to a recent medical event. The Company's Board of Directors has appointed Jeffrey T. Hanson, the Chairman of the Company's Board, to serve as Interim Chief Executive Officer and President, effective February 3, 2026, during Mr. Prosky's absence. Mr. Hanson will work closely with AHR's senior leade
IRVINE, Calif., Jan. 6, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company") (NYSE:AHR) announced today that it will issue its fourth quarter 2025 earnings release on Thursday, February 26, 2026, after the close of trading. A public conference call with a simultaneous webcast will be held on Friday, February 27, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. During the conference call, company executives will review fourth quarter and full year 2025 results, discuss recent events, and conduct a question-and-answer period. To join via webcast, investo
SC 13G - American Healthcare REIT, Inc. (0001632970) (Subject)
SC 13G/A - American Healthcare REIT, Inc. (0001632970) (Subject)
SC 13G/A - American Healthcare REIT, Inc. (0001632970) (Subject)